Administration Practice and Cost Effectiveness Analysis of Internet Anticoagulation Outpatient Service During the Novel Coronavirus Infection
10.3870/j.issn.1004-0781.2024.07.023
- VernacularTitle:新型冠状病毒感染期间互联网抗凝门诊管理实践及成本效果分析
- Author:
Wenbin SU
1
,
2
;
Mengfei DAI
;
Chen LAN
;
Lin ZHOU
;
Jifan ZHANG
;
Weihong GE
;
Feng YU
;
Hang XU
Author Information
1. 中国药科大学南京鼓楼医院药学部,南京 210008
2. 中国药科大学基础医学与临床药学学院,南京 210009
- Keywords:
Novel coronavirus;
Internet+;
Anticoagulation administration;
Cost-effectiveness analysis
- From:
Herald of Medicine
2024;43(7):1147-1150
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analysis the effectiveness and cost of Internet-based anticoagulation clinic versus traditional anticoagulation clinic treatment at Nanjing Drum Tower Hospital during the COVID-19 pandemic.Methods We reviewed and analyzed the clinical data of patients receiving anticoagulation management through Internet-based outpatient care and traditional outpatient care in Nanjing Drum Tower Hospital,from June 1,2020 to June 30,2021.Variability in time in therapeutic range(TTR)and international normalized ratio(INR)were calculated for enrolled patients.Patients meeting TTR≥60%and INR variability<0.65 were considered optimal anticoagulation quality.Cost-effectiveness analysis was conducted from the patients'perspective,with results expressed using the incremental cost-effectiveness ratio(ICER).Results In the"Internet-based anticoagulation outpatient care"and"traditional face-to-face anticoagulation outpatient care"groups,19 individuals(67.86%)and 67 individuals(76.14%)met the criteria for optimal anticoagulation quality,respectively.The mean TTR was(71.83±19.17)%in the Internet-based group and(71.74±23.41)%in the traditional face-to-face group,indicating similar levels of warfarin anticoagulation quality between the two groups.The ICER was calculated as 327.17 yuan,less than the per capita gross domestic product(GDP)of 2021.Conclusion During the COVID-19 pandemic,Nanjing Drum Tower Hospital's Internet-based anticoagulation outpatient care effectively complemented the government's epidemic control policies.It ensured equivalent anticoagulation outcomes and significantly reduced patients'financial burdens.This approach offers new insights and guidance for optimizing healthcare services in the post-pandemic era.
